Health Equity News – March 6, 2026 Roundup

This week’s focus on health equity and access reveals a complex landscape of shifting demographics, policy impacts, and persistent disparities in US healthcare. New data tracking young-onset colorectal cancer, Medicaid health gaps, and a surge in pediatric diabetes cases are among the key trends highlighted in the latest reports, alongside ongoing shifts in drug pricing that are reshaping care delivery in 2026.

Colorectal Cancer Trends in Younger Adults

Rising rates of colorectal cancer among younger adults continue to be a significant concern. While the data released this week doesn’t detail specific figures, the ongoing trend underscores the require for increased screening and awareness, particularly among individuals under 50. Current guidelines generally recommend routine screening beginning at age 45, but earlier detection may be warranted for those with family history or other risk factors. AJMC’s weekly roundup points to the need for further investigation into the causes of this increase, which may include dietary factors, lifestyle choices, and changes in the gut microbiome.

Medicaid Coverage and Health Gaps

Access to care through Medicaid remains a critical component of health equity, but recent data indicate persistent gaps in coverage and access to essential services. These gaps disproportionately affect vulnerable populations, including low-income individuals, racial and ethnic minorities, and those living in rural areas. The specific nature of these gaps – whether related to provider shortages, limited service availability, or administrative barriers – requires further scrutiny. Addressing these issues is crucial to ensuring that Medicaid effectively serves its intended purpose of providing affordable healthcare to those in need.

Pediatric Diabetes Cases on the Rise

A concerning spike in pediatric diabetes cases is drawing attention from public health officials. The reasons behind this increase are not yet fully understood, but potential contributing factors include rising rates of childhood obesity, changes in dietary patterns, and genetic predisposition. Early diagnosis and management of diabetes are essential to prevent long-term complications, such as cardiovascular disease, kidney failure, and vision loss. The AJMC report suggests a need for increased investment in diabetes prevention programs and improved access to pediatric endocrinology care.

Abortion Access: A Shifting Landscape

Recent data from the Guttmacher Institute, detailed in a February 20, 2026 report, paints a nuanced picture of abortion access in the post-Dobbs era. While the total number of brick-and-mortar abortion clinics in states without total bans has decreased only modestly—a 2% decline from 765 to 753 between March 2024 and December 2025—the overall situation is far more unstable. Key access states like New York and Illinois have experienced net clinic losses, and Florida has seen sharper declines following the implementation of a six-week ban. Newsbreak’s coverage highlights that 51 facilities stopped offering abortion care during this 21-month period, while 39 began or resumed services, creating significant disruption for patients.

The report emphasizes that legal protections alone are insufficient to guarantee access. Factors such as staffing shortages, financial constraints, geographic barriers, and patients’ ability to travel all play a role in shaping an increasingly uneven landscape. Telehealth and online-only providers are expanding, particularly in states with supportive policies, but approximately 80% of abortions in states where it remains legal still occur in physical clinics, which are essential for procedural and later-term care. The availability of medication abortion via mail, protected by shield laws in some states, offers a partial solution, but does not address the need for comprehensive in-person care.

Drug Pricing and Healthcare Costs

Shifts in drug pricing continue to be a major driver of healthcare costs in the US. The reports indicate ongoing efforts to address these costs through policy changes and market competition. However, the impact of these changes on patient access and affordability remains to be seen. The complexity of the pharmaceutical supply chain and the influence of pharmacy benefit managers (PBMs) present significant challenges to effective cost control. AJMC’s February 9th roundup noted ongoing debates surrounding PBM reforms and their potential to lower drug prices for consumers.

Understanding Prior Authorization Delays

A significant barrier to timely care remains the process of prior authorization, where insurance companies require pre-approval for certain medications or procedures. Delays in prior authorization can lead to treatment delays, adverse health outcomes, and increased healthcare costs. Efforts to streamline this process and reduce administrative burdens are ongoing, but progress has been slow. The impact of prior authorization is particularly acute for patients with chronic conditions who require ongoing medication management.

What comes next involves continued monitoring of these trends and a concerted effort to address the underlying systemic issues that contribute to health inequities. Further research is needed to understand the causes of rising colorectal cancer rates in younger adults and the recent surge in pediatric diabetes cases. Policymakers must prioritize policies that expand access to affordable healthcare, reduce administrative burdens, and promote health equity for all populations. Ongoing surveillance and data collection are essential to track progress and identify emerging challenges. The process of updating clinical guidelines and public health recommendations will require careful consideration of the latest evidence and input from stakeholders across the healthcare system.